Cortical Dysplasia Overview

Save information for later
Sign Up

Learn About Cortical Dysplasia

What is the definition of Cortical Dysplasia?
Cortical dysplasia is a condition present at birth (congenital) that occurs when the neurons in the top layer of the brain (cortex) develop abnormally. This causes the neurons to fire abnormally, causing seizures. Other causes of cortical dysplasia may include genetic disorders or brain injuries. Cortical dysplasia is the most common cause of epilepsy (seizures). The most common type of cortical dysplasia is focal cortical dysplasia (FCD), which is categorized into three types: Type 1 focal cortical dysplasia causes seizures that do not appear until adulthood, and usually involves the brain’s temporal lobe. Type II focal cortical dysplasia is found more frequently in children, involves the brain’s temporal and frontal lobes, and is more severe. Type III focal cortical dysplasia involves damage to another part of the brain, possibly from an early brain injury, in addition to Type 1 or Type II.
What are the symptoms of Cortical Dysplasia?
Symptoms of cortical dysplasia include seizures, learning disabilities, and developmental delays.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Cortical Dysplasia?
Treatment for cortical dysplasia is mainly focused on controlling the seizures and may include medications (antiepileptics) and a ketogenic diet. For seizures that cannot be controlled with medications or diet (intractable), brain surgery may recommended. If brain surgery is not an option, then treatment with vagal nerve stimulation (VNS) may be considered.
Who are the top Cortical Dysplasia Local Doctors?
Dr. David L. Ewing
Neurology
Dr. David L. Ewing
Neurology

Heartland Regional Medical Center

5325 Faraon St, 
Saint Joseph, MO 
 23.1 mi
Accepting New Patients
Languages Spoken English

David Ewing is a Neurologist in Saint Joseph, Missouri. Dr. Ewing and is rated as an Experienced provider by MediFind in the treatment of Cortical Dysplasia. His top areas of expertise are Memory Loss, Restless Legs Syndrome, Seizures, and Alzheimer's Disease. Dr. Ewing is currently accepting new patients.

Dr. Sreenadha R. Davuluri
Neurology
Dr. Sreenadha R. Davuluri
Neurology
105 Far West Drive, Suite 201, 
St Joseph, MO 
 23.3 mi
Accepting New Patients
Languages Spoken English, Telugu

Sreenadha Davuluri is a Neurologist in St Joseph, Missouri. Dr. Davuluri and is rated as an Experienced provider by MediFind in the treatment of Cortical Dysplasia. His top areas of expertise are Memory Loss, Seizures, Progressive Myoclonic Epilepsy, and Unverricht-Lundborg Syndrome. Dr. Davuluri is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Dr. Ammar H. Hawasli
Neurosurgery
Dr. Ammar H. Hawasli
Neurosurgery

Meritas Health Corporation

2750 Clay Edwards Dr, 410 Meritas Health Neurosur, 
North Kansas City, MO 
 52.0 mi
Accepting New Patients
Offers Telehealth
Languages Spoken English

Ammar Hawasli is a Neurosurgery provider in North Kansas City, Missouri. Dr. Hawasli and is rated as an Experienced provider by MediFind in the treatment of Cortical Dysplasia. His top areas of expertise are Cervical Spondylosis, Spondylolisthesis, Spinal Stenosis, Osteotomy, and Spinal Fusion. Dr. Hawasli is currently accepting new patients.

View All Doctors
What are the latest Cortical Dysplasia Clinical Trials?
Cutaneous Tumorigenesis in Patients With Tuberous Sclerosis
Cutaneous Tumorigenesis in Patients With Tuberous Sclerosis
Enrollment Status: Recruiting
Publish Date: January 15, 2025

Summary: Tuberous sclerosis is a rare, hereditary disease in which patients develop multiple tumors. Although not cancerous, the tumors can affect various organs, including the heart, lungs, kidneys, skin, and central nervous system, with serious medical consequences. The severity of disease varies greatly among patients, from barely detectable to fatal. This study will investigate what causes skin tumors ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
Enrollment Status: Recruiting
Publish Date: January 15, 2025
Intervention Type: Device

Summary: Pulmonary lymphangioleiomyomatosis (LAM) is a destructive lung disease typically affecting women of childbearing age. Currently, there is no effective therapy for the disease and the prognosis is poor. This study is designed to determine the disease processes involved at the level of cells and molecules, in order to develop more effective therapy. Researchers intend to identify the proteins and ge...

View All Clinical Trials